Astera Labs (ALAB) Stock Price Prediction: Mixed tape after record Q3 growth meets heavier selling pressure

What happened and why it matters

Astera Labs (ALAB) is sitting in a split setup: the company is still delivering strong fundamental growth, but the stock and derivatives tape are no longer confirming that momentum. On November 3, Astera Labs reported record third-quarter 2026 revenue of $584.9 million, up 49% sequentially and 154% year over year, with Scorpio fabric switches becoming the largest product family and the company expanding its portfolio across memory, optical and copper signal conditioning, plus rack-scale AI platforms. That is the fundamental anchor. citeturn0search0turn0search2

On the same arc, BMO initiated coverage on November 5 with an Outperform rating and a $375 target, framing ALAB as a critical AI networking leader benefiting from AI infrastructure build-out. That target is materially above the current price action, but it should be read as a medium-horizon analyst view, not a short-term trading map. citeturn0search0

Price action: holding up better than the tape, but not breaking out

The supplied market data shows ALAB at $224.62, down 3.19% in the last 24 hours, after trading between $219.88 and $238.18. The stock remains above its 7-day average of $208.26 and its 12-day EMA of $222.09, but it is still below the 20-day SMA of $236.77 and the 50-day SMA of $293.15. That leaves the chart in an intermediate state: short-term stabilization, but not yet a clean trend reversal. citeturn0search0

The technical readout labels the structure an “oversold rebound attempt,” which fits the layout. ALAB is extended above its 7-day average by 7.85%, yet still sits 5.13% below the 20-day average, a setup that often produces choppy mean reversion rather than immediate trend expansion. citeturn0search0

Momentum and volume: neutral RSI, bearish MACD, low-volume pullback

Momentum is mixed. The 14-period RSI is 42.15, which is neutral but leaning soft, while the MACD is -22.2351 with a flat histogram, pointing to still-negative momentum rather than a confirmed acceleration lower. Stochastic readings at 48.75 and 39.00 also suggest the stock is not deeply stretched either way. citeturn0search0

Volume context matters here. The volume-price regime is only 0.37x versus the 5-day average, which the dataset classifies as a low-volume pullback and constructive consolidation. That argues against panic selling, but it also says the market has not yet committed to a decisive bounce. citeturn0search0

Key levels traders will watch

The nearest pivot is $227.56, with immediate resistance at $235.24 and stronger resistance at $245.86. On the downside, immediate support sits at $216.94, with strong support at $209.26. Those levels are close enough to the current price to define the next move cleanly: a push through $235.24 would improve the short-term structure, while failure back through $216.94 would reopen the lower support band. citeturn0search0

The Bollinger setup reinforces that framing. The middle band is $236.77, the upper band is $302.82, and the lower band is $170.72, with %B at 0.4080. ALAB is below the mid-band, which means the stock has not yet reclaimed the center of its recent range. citeturn0search0

Binance Futures positioning: cautiously constructive, but not decisive

Binance perpetual futures data show neutral 8-hour funding at 0.0000%, so there is no clear leverage premium either way. Open interest is 3,038.95 contracts, worth $704,671 daily, and is up 1.49% over 24 hours, which suggests participation is still there even as the price pulled back. citeturn0search0

The long/short ratios lean long: global accounts are 58.6% long versus 41.4% short, and top traders are 67.5% long versus 32.5% short as of 2026-11-12 11:00 UTC. That is not a guarantee of upside; it simply shows more accounts are positioned for strength than weakness. The wrinkle is the taker buy/sell ratio of 0.6386, with 304 in buy volume versus 476 in sell volume, which points to more aggressive selling pressure in the latest window. citeturn0search0

What would invalidate the rebound case

For the rebound to hold water, ALAB needs to reclaim the $235.24 to $236.77 zone and prove that the latest dip was just a pause beneath the 20-day average. If it cannot hold $216.94, the chart weakens quickly, and a move toward $209.26 becomes the more relevant downside test. The ATR(14) of $22.91 also warns that swings can be wide enough to cut through nearby levels fast, so clean invalidation matters more than wishful intraday recoveries. citeturn0search0

The real story is not a simple bullish or bearish call. Astera Labs still has a powerful fundamental growth case and a fresh analyst endorsement from BMO, but the stock needs price confirmation before the market can say the recent pullback is finished.